BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12779325)

  • 1. 2.4 A resolution crystal structure of the prototypical hormone-processing protease Kex2 in complex with an Ala-Lys-Arg boronic acid inhibitor.
    Holyoak T; Wilson MA; Fenn TD; Kettner CA; Petsko GA; Fuller RS; Ringe D
    Biochemistry; 2003 Jun; 42(22):6709-18. PubMed ID: 12779325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for differences in substrate selectivity in Kex2 and furin protein convertases.
    Holyoak T; Kettner CA; Petsko GA; Fuller RS; Ringe D
    Biochemistry; 2004 Mar; 43(9):2412-21. PubMed ID: 14992578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between S1 and S4 subsites in Kex2 protease: Kex2 exhibits dual specificity for the P4 side chain.
    Rockwell NC; Fuller RS
    Biochemistry; 1998 Mar; 37(10):3386-91. PubMed ID: 9521659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and function of eukaryotic proprotein processing enzymes of the subtilisin family of serine proteases.
    Van de Ven WJ; Roebroek AJ; Van Duijnhoven HL
    Crit Rev Oncog; 1993; 4(2):115-36. PubMed ID: 8420571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered eglin c variants inhibit yeast and human proprotein processing proteases, Kex2 and furin.
    Komiyama T; Fuller RS
    Biochemistry; 2000 Dec; 39(49):15156-65. PubMed ID: 11106495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kindest cuts of all: crystal structures of Kex2 and furin reveal secrets of precursor processing.
    Rockwell NC; Thorner JW
    Trends Biochem Sci; 2004 Feb; 29(2):80-7. PubMed ID: 15102434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct measurement of acylenzyme hydrolysis demonstrates rate-limiting deacylation in cleavage of physiological sequences by the processing protease Kex2.
    Rockwell NC; Fuller RS
    Biochemistry; 2001 Mar; 40(12):3657-65. PubMed ID: 11297433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoproteolytic processing of recombinant proalbumin variants by the yeast Kex2 protease.
    Ledgerwood EC; George PM; Peach RJ; Brennan SO
    Biochem J; 1995 May; 308 ( Pt 1)(Pt 1):321-5. PubMed ID: 7755581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity characterization of the α-mating factor hormone by Kex2 protease.
    Manfredi MA; Antunes AA; Jesus LO; Juliano MA; Juliano L; Judice WA
    Biochimie; 2016 Dec; 131():149-158. PubMed ID: 27720750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential utilization of enzyme-substrate interactions for acylation but not deacylation during the catalytic cycle of Kex2 protease.
    Rockwell NC; Fuller RS
    J Biol Chem; 2001 Oct; 276(42):38394-9. PubMed ID: 11514565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synthesis of inhibitors for processing proteinases and their action on the Kex2 proteinase of yeast.
    Angliker H; Wikstrom P; Shaw E; Brenner C; Fuller RS
    Biochem J; 1993 Jul; 293 ( Pt 1)(Pt 1):75-81. PubMed ID: 8328974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kex2-like proteolytic activity in adrenal medullary chromaffin granules.
    Azaryan AV; Hook VY
    Biochem Biophys Res Commun; 1992 May; 185(1):398-403. PubMed ID: 1599477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of protease-inhibitor interactions by randomizing adventitious contacts.
    Komiyama T; VanderLugt B; Fugère M; Day R; Kaufman RJ; Fuller RS
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8205-10. PubMed ID: 12832612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The crystal structure of the proprotein processing proteinase furin explains its stringent specificity.
    Henrich S; Cameron A; Bourenkov GP; Kiefersauer R; Huber R; Lindberg I; Bode W; Than ME
    Nat Struct Biol; 2003 Jul; 10(7):520-6. PubMed ID: 12794637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and enzymatic characterization of a purified prohormone-processing enzyme: secreted, soluble Kex2 protease.
    Brenner C; Fuller RS
    Proc Natl Acad Sci U S A; 1992 Feb; 89(3):922-6. PubMed ID: 1736307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internally consistent libraries of fluorogenic substrates demonstrate that Kex2 protease specificity is generated by multiple mechanisms.
    Rockwell NC; Wang GT; Krafft GA; Fuller RS
    Biochemistry; 1997 Feb; 36(7):1912-7. PubMed ID: 9048578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A C-terminal domain conserved in precursor processing proteases is required for intramolecular N-terminal maturation of pro-Kex2 protease.
    Gluschankof P; Fuller RS
    EMBO J; 1994 May; 13(10):2280-8. PubMed ID: 8194519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and rational mutagenesis of kexstatin I, a potent proteinaceous inhibitor of Kex2 proteinase.
    Oda K; Oyama H; Ito S; Fukiharu M; Miyagawa Y; Takahashi S; Hirose M; Kikuchi N; Nakayama T; Shibano Y
    Biochem J; 2001 Apr; 355(Pt 2):339-46. PubMed ID: 11284720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray structures of five renin inhibitors bound to saccharopepsin: exploration of active-site specificity.
    Cronin NB; Badasso MO; J Tickle I; Dreyer T; Hoover DJ; Rosati RL; Humblet CC; Lunney EA; Cooper JB
    J Mol Biol; 2000 Nov; 303(5):745-60. PubMed ID: 11061973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-mediated thermostability in the subtilisin superfamily: the crystal structure of Bacillus Ak.1 protease at 1.8 A resolution.
    Smith CA; Toogood HS; Baker HM; Daniel RM; Baker EN
    J Mol Biol; 1999 Dec; 294(4):1027-40. PubMed ID: 10588904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.